Bain & Company Partner Christian Mazzi believes the speciality generic pharmaceutical space is now one of the hottest "here and now" themes for private equity firms. Mazzi, who leads Bain's London Healthcare practice, told Private Healthcare Investor that specialist generic firms have traditionally been the domain of specialist healthcare private equity firms, but that the landscape was now shifting towards the generalist firms.